Financial hardship after cancer: revision of a conceptual model and development of patient-reported outcome measures

References

• Ehsan AN, Wu CA, Minasian A et al. Financial toxicity among patients with breast cancer worldwide: a systematic review and meta-analysis. JAMA Netw. Open 6(2), e2255388 (2023).
   PubMed Web of Science ®Google Scholar
• Zafar SY, Abernethy AP. Financial toxicity, Part II: how can we help with the burden of treatment-related costs? Oncology (Williston Park) 27(4), 253–254; 256 (2013).
   PubMed Web of Science ®Google Scholar
• Zafar SY, Abernethy AP. Financial toxicity, Part I: a new name for a growing problem. Oncology (Williston Park) 27(2), 80–81; 149 (2013).
   PubMed Web of Science ®Google Scholar
• Jones SMW, Nguyen T, Chennupati S. Association of financial burden with self-rated and mental health in older adults with cancer. J. Aging Health 32(5–6), 394–400 (2020).
   PubMed Web of Science ®Google Scholar
• Benedict C, Fisher S, Schapira L et al. Greater financial toxicity relates to greater distress and worse quality of life among breast and gynecologic cancer survivors. Psychooncology 31(1), 9–20 (2022).
   PubMed Web of Science ®Google Scholar
• Ver Hoeve ES, Ali-Akbarian L, Price SN, Lothfi NM, Hamann HA. Patient-reported financial toxicity, quality of life, and health behaviors in insured US cancer survivors. Support. Care Cancer 29(1), 349–358 (2021).
   PubMed Web of Science ®Google Scholar
• Hazell SZ, Fu W, Hu C et al. Financial toxicity in lung cancer: an assessment of magnitude, perception, and impact on quality of life. Ann. Oncol. 31(1), 96–102 (2020).
   PubMed Web of Science ®Google Scholar
• Evans LA, Go R, Warsame R et al. The impact of socioeconomic risk factors on the survival outcomes of patients with newly diagnosed multiple myeloma: a cross-analysis of a population-based registry and a tertiary care center. Clin. Lymph. Myel. Leuk. 21(7), 451–460; e452 (2021).
   PubMed Web of Science ®Google Scholar
• Ramsey SD, Bansal A, Fedorenko CR et al. Financial insolvency as a risk factor for early mortality among patients with cancer. J. Clin. Oncol. 34(9), 980–986 (2016).
   PubMed Web of Science ®Google Scholar
• Goulart BHL, Unger JM, Chennupati S, Fedorenko CR, Ramsey SD. Out-of-pocket costs for tyrosine kinase inhibitors and patient outcomes in EGFR- and ALK-positive advanced non-small-cell lung cancer. JCO Oncol. Pract. 17(2), e130–e139 (2021).
   PubMedGoogle Scholar
• Gordon LG, Merollini KMD, Lowe A, Chan RJ. A systematic review of financial toxicity among cancer survivors: we can't pay the co-pay. Patient 10(3), 295–309 (2017).
   PubMedGoogle Scholar
• Altice CK, Banegas MP, Tucker-Seeley RD, Yabroff KR. Financial hardships experienced by cancer survivors: a systematic review. J. Natl Cancer Inst. 109(2) (2017).
   PubMedGoogle Scholar
• Jones SM, Henrikson NB, Panattoni L, Syrjala KL, Shankaran V. A theoretical model of financial burden after cancer diagnosis. Future Oncol. 16(36), 3095–3105 (2020).
   PubMed Web of Science ®Google Scholar
• Doherty M, Gardner D, Finik J. The financial coping strategies of US cancer patients and survivors. Support. Care Cancer 29(10), 5753–5762 (2021).
   PubMed Web of Science ®Google Scholar
• Consumer Financial Protection Bureau. Measuring financial well-being: a guide to using the CFPB Financial Well-Being Scale. (2015). https://www.consumerfinance.gov/data-research/research-reports/financial-well-being-scale/
   Google Scholar
• Archuleta KL, Dale A, Spann SM. College students and financial distress: exploring debt, financial satisfaction, and financial anxiety. J. Finan. Counsel. Plan. 24(2), 50–62 (2013).
   Google Scholar
• De Souza JA, Yap BJ, Hlubocky FJ et al. The development of a financial toxicity patient-reported outcome in cancer: the COST measure. Cancer 120(20), 3245–3253 (2014).
   PubMed Web of Science ®Google Scholar
• De Souza JA, Yap BJ, Wroblewski K et al. Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST). Cancer 123(3), 476–484 (2017).
   PubMed Web of Science ®Google Scholar
• Head BA, Faul AC. Development and validation of a scale to measure socioeconomic well-being in persons with cancer. J. Support Oncol. 6(4), 183–192 (2008).
   PubMedGoogle Scholar
• Jones S, Du YX, Panattoni L, Henrikson N. Development of a questionnaire to assess worry about affording healthcare in an international sample. Qual. Life Res. 28, S54–S54 (2019).
   Web of Science ®Google Scholar
• Jones SMW, Amtmann D. Health care worry is associated with worse outcomes in multiple sclerosis. Rehabil. Psychol. 59(3), 354–359 (2014).
   PubMed Web of Science ®Google Scholar
• Medical Expenditure Panel Survey. (September 3, 2014). http://meps.ahrq.gov/mepsweb/
   Google Scholar
• Survey Description, National Health Interview Survey, 2017. (2018). https://www.cdc.gov/nchs/nhis/index.htm
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. (5). American Psychiatric Association, Arlington, VA (2013).
   Google Scholar
• Elo S, Kyngas H. The qualitative content analysis process. J. Advan. Nursing 62(1), 107–115 (2008).
   PubMed Web of Science ®Google Scholar
• Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual. Health Res. 15(9), 1277–1288 (2005).
   PubMed Web of Science ®Google Scholar
• Whitley R, Crawford M. Qualitative research in psychiatry. Canadian journal of psychiatry. Revue Canadienne de Psychiatrie 50(2), 108–114 (2005).
   PubMed Web of Science ®Google Scholar
• Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ. Today 24(2), 105–112 (2004).
   PubMed Web of Science ®Google Scholar
• Yabroff KR, Dowling EC, Guy GP et al. Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors. J. Clin. Oncol. 34(3), 259–267 (2016).
   PubMed Web of Science ®Google Scholar
• Yabroff KR, Zhao J, Han X, Zheng Z. Prevalence and correlates of medical financial hardship in the USA. J. Gen. Intern. Med. 34(8), 1494–1502 (2019).
   PubMed Web of Science ®Google Scholar
• Albelda R, Wiemers E, Hahn T, Khera N, Salas Coronado DY, Abel GA. Relationship between paid leave, financial burden, and patient-reported outcomes among employed patients who have undergone bone marrow transplantation. Qual. Life Res. 28(7), 1835–1847 (2019).
   PubMed Web of Science ®Google Scholar
• De Boer AG, Torp S, Popa A et al. Long-term work retention after treatment for cancer: a systematic review and meta-analysis. J. Cancer Surviv. 14(2), 135–150 (2020).
   PubMed Web of Science ®Google Scholar
• Housser E, Mathews M, Lemessurier J, Young S, Hawboldt J, West R. Responses by breast and prostate cancer patients to out-of-pocket costs in Newfoundland and Labrador. Curr. Oncol. 20(3), 158–165 (2013).
   PubMed Web of Science ®Google Scholar
• Buttner M, Konig HH, Lobner M et al. Out-of-pocket-payments and the financial burden of 502 cancer patients of working age in Germany: results from a longitudinal study. Support. Care Cancer 27(6), 2221–2228 (2019).
   PubMed Web of Science ®Google Scholar
• Fitzpatrick SL, Papajorgji-Taylor D. Social risk-informed care: scoping review and qualitative research to inform implementation at Kaiser Permanente. 1–34 (2021).
   Google Scholar
• CDER patient-focused drug development. (6/22/2023). https://www.fda.gov/drugs/development-approval-process-drugs/cder-patient-focused-drug-development
   Google Scholar